Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 25 May 2021 07:00 CEST |
NORDIC NANOVECTOR | Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |